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Model of congruency determined molecular
coevolution: from homophilic binding to
ligand/receptor pairs
Abstract
Peptide hormones depend on reliable recognition by their receptors,
based on congruency. If a mutation changes the surface of one of interacting
molecules and creates a confined space, a niche, in the otherwise congruent
hormone/receptor interface, this would allow further mutations confined to
the niche space, until one change in molecular shape fills the entire niche
space and stops further mutations. Repetition of this process might lead to a
different ligand/receptor pair that shows only remote similarities to the
initial pair. This paper is aiming to use this model of congruency determined
coevolution on homophilic membrane molecules to describe evolution of
endocrine and paracrine ligands and receptors.
During evolution, a gene of some ancient homophilic membrane molecule
with intracellular enzymatic activity might have been duplicated. A new pair
of genes (A & B) evolved toward heterophilic binding. Expression of molecu-
les from both genes on neighboring cells might allow congruency-determined
coevolution that resulted in heterophilic recognition (A-B and B-A).
Loss of intracellular domains could make one of heterophilic molecules
soluble (protoligands) that recognized membrane molecules on other cells
(protoreceptors) as a first ligand/receptor pair. New pairs are formed through
gene duplication and separate coevolution leading to families of receptors
and families of ligands.
Survival pressure forces receptors to remain sensitive and specific, while
ligands shrink until they are as small as feasible. Occasionally, plant toxins
mimic endogenous peptides (morphine versus endorphins), or receptors can
become able to interact with nonpeptide endogenous ligands (steroids,
catecholamines). Further receptor evolution congruent to the new ligand can
make the initial peptide ligand unrecognizable by that receptor (example:
membrane receptors for steroids are without known peptide ligands). Finally,
lipid soluble ligands can interact with receptors before receptor molecules
reach the cell membrane and are still in the cytoplasm. This can make
functional membrane receptors less important (aldosterone, estrogen) or
abandoned (other steroids, thyroid hormones).
INTRODUCTION
Action of peptide hormones depends on functional membrane re-ceptors that can specifically recognize ligand molecules. Since
receptors and ligands are products of separate genes, any alteration in
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Hypothesis
for both molecules conserved during evolution and the
everlasting question of explaining the occurrence of li-
gand/receptor pairs remains to be solved.
Although most of the hormones from one mamma-
lian species are active when injected into another, the
incompatibility of human GH receptor (GHR) toward
non primate GHs is a notable exception (1). GH species
specifity was recently interpreted as a congruency-deter-
mined coevolution of GH and GHR molecules that al-
lowed conservation of both molecules to be interrupted
by periods of accelerated evolution (2). Coevolution was





Peptide hormones that regulate electrolytes, glucose,
or any other important regulatory mechanisms depend
on reliable recognition by their receptors (as shown in
Fig 1A). Specifity and sensitivity are required. Any mu-
tation in one of the involved molecules would endanger
survival of the mutation carrier if it compromises re-
cognition and interaction of hormone and receptor mo-
lecules (Fig. 1B). The carrier animal of such a trait would
not procreate, and the mutation would be lost for evolu-
tion. In other words, only mutations that do not com-
promise recognition based on congruency are allowed.
Well-known examples are few amino acid mutations
found in insulins of different animals.
A rare situation can be expected when a mutation
changes the surface of one of the interacting molecules
and creates a confined space, a niche, in the otherwise
congruent hormone/receptor interface (Fig. 1C). Although
affinity between molecules is probably slightly reduced,
recognition and function are not compromised. Forma-
tion of this niche allows occurrence of further mutations
of both interacting molecules, if they remain confined to
the niche space (Fig. 1D&E). This period of accelerated
evolution can be abruptly stopped if one consequent
mutation fills the entire niche space (Fig. 1F) and stops
further mutations conserving a new ligand/receptor pair.
The process can be repeated during evolution leading to
almost fully different ligand/receptor pairs that show
only remote similarities in their structure.
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Figure 1. Schematic presentation of the proposed model of two
molecules that base their recognition on congruency. A/ initial pair of
highly congruent molecules; B/ majority of mutations compromise
molecule bonding and are lost in evolution; C/ a mutation that does
not compromise molecule binding and leaves space for further mu-
tations of both molecules; D&E/ examples of possible mutations
within the allowed space that do not compromise binding; F/ the
sealing mutation filled the empty niche and prevented further muta-
tions. Note that both molecules differ from case A.
Figure 2. Schematic presentation of the proposed scenario from Table
1. A/ Homophilic binding of extracellular domains of membrane
molecules in first multicellular organisms might be the first step
toward endocrine/paracrine loops. B to F/ Gene duplication forms a
pair of molecules expressed on neighboring cells and allows congruen-
cy determined coevolution that leads to heterophilic recognition (A-B
and B-A) and reduces homophilic recognition (A-A or B-B).G/ Loss
of intracellular domain leads to secretion of soluble heterophilic mole-
cules (protoligands) that recognize membrane molecules on other cells
(protoreceptors)H/Receptors can become sensitive to plant toxins that
mimic endogenous peptides, or they can become able to interact with
nonpeptide endogenous ligands (steroids, catecholamines).
The aim of this paper was to use the same model of
congruency-determined coevolution of initially homo-




HOMOPHILIC BINDING IN BIOLOGY
This paper was inspired by the accumulated data on
homophilic binding in diverse areas of biology. Reported
data show that the same molecule can be homophilic and
heterophilic, suggesting frequent evolutionary transition
from one type of molecular binding to the other.
Cadherins are homophilic and heterophilic cell adhe-
sion molecules involved in tissue morphogenesis and the
maintenance of tissue architecture in adults (4). In the ad-
hesive interaction between E-cadherin and alpha(E)beta7,
domain 5 is involved in heterophilic, but not in homo-
philic adhesion as other domains are (5). Receptor pro-
tein tyrosine phosphatases (RPTPs) can mediate either
homophilic or heterophilic interactions and suggest a
role in cadherin-mediated cell-cell adhesion (6). Ne-
phrin is a signaling cell-cell adhesion protein of the Ig
superfamily with extracellular domains that form a net-
work of homophilic and heterophilic interactions build-
ing the structural scaffold of the slit diaphragm between
the podocyte foot processes (7). SC1 is another immuno-
globulin superfamily cell adhesion molecule that shows
homophilic binding activity with itself (8). Human NK
cells can be activated by the SLAM-related receptors
(SRR) with homophilic interaction (9). Erythroblast ma-
crophage protein, expressed on erythroblasts and macro-
phages, mediates cell-cell attachments via homophilic
binding (10). Human monocyte-derived macrophages
capture viable and apoptotic human leukocytes through
homophilic interactions of CD31 present on both cells
(11). The neural cell adhesion molecule, NCAM, is in-
volved in multiple cis- and trans-homophilic interactions
(NCAM binding to NCAM), helping cell-cell adhesion
through the formation of zipper-like NCAM-complexes
(12), and heterophilic (NCAM-fibroblast growth factor
receptor) interactions (13, 14) with heparan sulfate and
chondroitin sulfate glycoconjugates (15). The MEGF1
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TABLE 1
Short description of the presented concept in which homophilic membrane molecules through gene duplication
form a pair of molecules that evolve in heterophilic binding and finally in pairs of soluble peptide ligands and mem-
brane-based receptors. Further evolution can introduce nonpeptide ligands and nonmembrane receptors.
Phases of the ligand/receptor
development
Concept of congruency-determined ligand/receptor coevolution
Membrane proteins homophilic interaction of membrane bound
proteins
recognition A-A
duplication of genes for
homophilic proteins
expression of molecules from both genes (A
& B) on neighboring cells
allows congruency-determined coevolution that
leads to heterophilic recognition (A-B, B-A) and
reduces homophilic recognition (A-A or B-B)
soluble forms of initially
membrane bound molecules
loss of intracellular domain of one of
heterophilic molecules
leads to secretion of soluble heterophilic mole-
cules (protoligands) that recognize membrane
molecules on other cells (protoreceptors)
duplication of genes new ligand/receptor pairs are formed
through gene duplication
separate coevolutions lead to families of receptors
and families of ligands
congruency-determined
ligand/receptor coevolution
receptors remain sensitive and specific, while
ligands become as small as feasible
hypothalamic hormones: small enough just to
reach adenohypophysis
quick action hormones: peptides up to 50 AA
slow action hormones: up to 200 AA, or in com-
plex with binding proteins (IGF-I, GH)
introduction of nonprotein
ligands
External nonpeptide agonists can activate re-
ceptors for endogenous peptides
morphine instead of endorphins
Receptor evolution can make membrane re-
ceptors sensitive to nonpeptide molecules
steroids, catecholamines etc.
If new ligands become dominant, receptor
evolution makes the initial peptide ligand
unrecognizable by that receptor




lipid soluble ligands can interact with recep-
tor molecules while they are still in the cyto-
plasm
membrane receptors become less important
(aldosteron, estrogen), or obsolete (steroids with-
out membrane receptors, thyroid hormones)
gene encodes a very large protein containing two EGF-
like and 34 cadherin motifs (16). Plexins act as receptors
of semaphorins, but plexin B3 also shows homophilic
interaction in semaphorin-independent signaling mecha-
nisms (17). The homophilic junctional adhesion mole-
cule C (JAM-C) was shown to undergo a heterophilic
interaction with the leukocyte beta2 integrin Mac-1 (18).
THE PROPOSED SCENARIO OF THE
OCCURRERNCE OF LIGANDS/RECEPTOR
PAIRS
The basic idea, shown in Fig. 2 and described in Table
1., is that the homophilic binding of extracellular do-
mains of membrane molecules could, in early multi-
cellular organisms, be the first step toward development
of endocrine/paracrine loops (Fig. 2A).
During evolution a gene of some ancient homophilic
membrane molecule capable of intracellular enzymatic
activity might have been duplicated, producing a pair of
genes whose proteins evolved from homophilic to hete-
rophilic binding. As shown in Figure 2., expression of
molecules from both genes (A & B) on neighboring cells
(Fig. 2B) allowed congruency-determined coevolution
(Fig. 2C to F) that resulted in heterophilic recognition
(A-B and B-A) and reduced homophilic recognition (A-A
or B-B). Eventual loss of intracellular domain sequence
in the gene responsible for one of heterophilic molecules
produced soluble molecules (acting as protoligands) that
recognized membrane molecules on other cells (acting
as protoreceptors) (Fig. 2G). New ligand/receptor pairs
were formed through further gene duplication and se-
parate coevolution of these pairs produced families of re-
ceptors and families of ligands, as we know them now.
Survival pressure forces receptors to remain sensitive
and specific, while ligands shrink until they are as small
as feasible. Occasionally, plant toxins mimic endogenous
peptides (morphine versus endorphins), or receptors can
become able to interact with nonpeptide endogenous
ligands (steroids, catecholamines)(Fig. 2H). It is also
possible that one ligand interacts with two receptors that
differ in structure, as it is known for IGF interacting with
type I and type II receptors of different structures (19).
Further receptor evolution congruent to the new li-
gand can make the initial peptide ligand unrecognizable
by that receptor (example: membrane receptors for ste-
roids are without known peptide ligands). Finally, lipid
soluble ligands can interact with receptors before re-
ceptor molecules reach the cell membrane and are still in
the cytoplasm. This can make functional membrane re-
ceptors less important (aldosterone, estrogen) or aban-
doned (other steroids, thyroid hormones).
CONCLUSIONS
The consequences of the proposed concept are shown
in Fig. 3. Receptors, paracrine and endocrine peptide
ligands might have all originated from homophilic mem-
brane molecules with intracellular enzymatic activities.
Through gene duplication and congruency-determined
coevolution, new molecular interfaces formed, ligands
became soluble and optimally small while receptors re-
mained sensitive and specific. Part of this peptide en-
docrine and paracrine system was later taken over by
nonpeptide agonists while initial peptide ligands were
abandoned. Some of them induced occurrence of in-
tracellular receptors.
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